Extension Study of Asenapine {P06107 (NCT01244815)} for Pediatric Bipolar Disorder (P05898 AM3)

Inclusion Criteria:

- Completed study P06107 and demonstrated acceptable degree of compliance with
medication, visits and other study requirements

- Must be male or a female who is not of childbearing potential or who is not pregnant,
not lactating, and is using a medically accepted method of contraception

- Must have a caregiver or responsible person living with the participant who agrees to
provide support to ensure compliance with treatment, visits, and protocol procedures

Exclusion Criteria:

- Positive pregnancy test or intention to become pregnant during the study

- At imminent risk of self-harm or harm to others

- Under involuntary inpatient commitment

- Known serological evidence of human immunodeficiency virus (HIV) antibody